Kolon Tissuegene, Inc.
Clinical trials sponsored by Kolon Tissuegene, Inc., explained in plain language.
-
Single shot could ease arthritic knee pain for years
Disease control OngoingThis study is testing whether a single injection called TG-C can safely reduce pain and improve function in people with moderate knee osteoarthritis. Researchers are comparing the injection to a placebo (saltwater) shot in 531 participants over two years. The goal is to see if th…
Phase: PHASE3 • Sponsor: Kolon TissueGene, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
One-Shot hope for aching knees
Disease control OngoingThis study is testing whether a single injection called TG-C can help people with moderate knee arthritis. It aims to reduce pain and improve knee function over two years. The injection is compared to a placebo (saltwater) shot to see which works better.
Phase: PHASE3 • Sponsor: Kolon TissueGene, Inc. • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC